Home›Stock Screener›Dr Reddys Laboratories›Quarterly Results

Dr Reddys Laboratories Quarterly Results

Latest Quarter Net Profit
₹221 Cr
QMar 2026
Quarterly Results

Dr Reddys Laboratories quarterly results. In Mar 2026, Dr Reddys Laboratories (DRREDDY) reported revenue ₹7,996 Cr and net profit ₹221 Cr — revenue -11.5% YoY. Review DRREDDY price earnings ratio to evaluate earnings-based valuation against sector peers.

DRREDDY Quarterly Results — Revenue, Profit & EPS Highlights

Dr Reddys Laboratories latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. For annual financials, live price and key ratios, visit DRREDDY stock price BSE.

  • Revenue of ₹7,996 Cr in Mar 2026 (-5.1% vs Jun 2026, -11.5% vs Mar 2025)
  • Net Profit of ₹221 Cr in Mar 2026 (-49.3% vs Jun 2026, -86.1% vs Mar 2025)
  • EBITDA of ₹832 Cr in Mar 2026 (-29.8% vs Jun 2026)
  • Operating Margin of 5.0% in Mar 2026 (-5.0pp vs Jun 2026)
  • Earnings Per Share of ₹2.65 in Mar 2026 (-50.3% vs Jun 2026)

Dr Reddys Laboratories Quarterly Results — Revenue, EBITDA, Net Profit & EPS

DRREDDY quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Mar 2026 Jun 2026 Sept 2025 Mar 2025 Jun 2025 QoQ YoY
Revenue (₹ Cr) 7,996 8,426 9,135 9,034 8,836 -5.1% -11.5%
Net Profit (₹ Cr) 221 436 1,337 1,587 1,410 - -
EBITDA (₹ Cr) 832 1,186 2,317 2,503 2,437 - -
EPS (₹) 2.65 5.33 16.18 19.12 17.04 - -
Operating Margin (%) 5.0% 10.0% 23.0% 23.0% 25.0% - -

DRREDDY Share Price Trend — 1-Year Movement Across Quarterly Results

Dr Reddys Laboratories 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Check DRREDDY market capitalization to track the company's total market size over time.

Profitability Ratios

Profit Margin 2.8%
EBITDA Margin 10.4%
Operating Margin 5.0%
ROE (Annual) 2.3%

Balance Sheet Highlights

Total Assets ₹58,123 Cr
Total Equity ₹38,231 Cr
Current Assets ₹ Cr
Current Liabilities ₹3,145 Cr

Cash Flow Analysis

Operating Cash Flow ₹5,674 Cr
Investing Cash Flow ₹-6,425 Cr
Financing Cash Flow ₹829 Cr
Net Cash Flow ₹78 Cr

Current Market Data

Current Price ₹1239.00
Exchange NSE
Last Updated Oct 22, 2026

Revenue Trend (₹ Cr)

Mar 2025 9,034
Sept 2025 9,135
Jun 2026 8,426
Mar 2026 7,996

Net Profit Trend (₹ Cr)

Mar 2025 1,587
Sept 2025 1,337
Jun 2026 436
Mar 2026 221

Operating Margin Trend (%)

Mar 2025 23.0%
Sept 2025 23.0%
Jun 2026 10.0%
Mar 2026 5.0%

DRREDDY vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

Dr Reddys Laboratories latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Mar 2026 		₹421,995.00 Cr 1758.0 15,018 2,710 -5.6% - 18.0% 155.6
Divis Laboratories
Mar 2026 		₹241,231.30 Cr 9162.0 2,986 751 -5.0% - 25.2% 323.6
Torrent Pharmaceuti…
Mar 2026 		₹188,719.51 Cr 4615.3 4,111 364 +27.7% +42.2% 8.9% 401.0
Laurus Labs
Mar 2026 		₹111,790.60 Cr 2002.5 1,823 282 -10.5% - 15.5% 387.3
Zydus Life Science
Mar 2026 		₹111,111.95 Cr 1135.0 7,569 1,341 -4.3% - 17.7% 89.7
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data

QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores